Purdue Pharma

In three weeks, a West Virginia judge will take up a request to unseal court documents that include details about OxyContin-maker Purdue Pharma’s deceptive sales practices. The contents of the entire court file have remained secret for two decades.

On this West Virginia Morning, we have all the details on West Virginia Senate races statewide. Also, in this show, we hear from an expert about the recent $8 billion Purdue Pharma settlement and whether that will help families devastated by the business practices that led so many to become addicted to pain pills.

Purdue Pharma, the company that makes OxyContin, the powerful prescription painkiller that experts say helped touch off an opioid epidemic, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday.

The federal judge overseeing the bankruptcy case of OxyContin maker Purdue Pharma set a June 30 deadline to file claims against the company. That includes…

According to a court filing Monday, the family pulled about $10.7 billion from Purdue since 2008 — ramping up withdrawals even after executives pleaded guilty to misleading regulators about OxyContin.

A federal bankruptcy judge on Wednesday agreed to keep nearly 2,700 lawsuits against OxyContin maker Purdue Pharma and hundreds more against the family…

The bankruptcy follows the Sackler family, which owns Purdue, agreeing to surrender control of the company and offering $3 billion in cash to opioid-hit communities.

In the late 1990s, the tobacco industry agreed to pay billions of dollars in fines to state governments to offset some of the medical costs associated…

A group of state attorneys general negotiating with members of the Sackler family says they expect Purdue Pharma to file for bankruptcy "imminently," according to an email obtained by NPR.

Purdue Pharma, Johnson & Johnson and other health care giants are discussing potential deals with authorities that could resolve thousands of lawsuits they're facing over the U.S. opioid epidemic.